Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

NAMI vs CLPS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
NAMI
Jinxin Technology Holding Company American Depositary Shares

Internet Content & Information

Communication ServicesNASDAQ • CN
Market Cap$11M
5Y Perf.-90.5%
CLPS
CLPS Incorporation

Information Technology Services

TechnologyNASDAQ • HK
Market Cap$25M
5Y Perf.-22.6%

NAMI vs CLPS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
NAMI logoNAMI
CLPS logoCLPS
IndustryInternet Content & InformationInformation Technology Services
Market Cap$11M$25M
Revenue (TTM)$406M$299M
Net Income (TTM)$20M$-4M
Gross Margin28.8%22.8%
Operating Margin6.7%-1.4%
Forward P/E3.6x
Total Debt$6M$34M
Cash & Equiv.$93M$28M

NAMI vs CLPSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

NAMI
CLPS
StockDec 24May 26Return
Jinxin Technology H… (NAMI)1009.5-90.5%
CLPS Incorporation (CLPS)10077.4-22.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: NAMI vs CLPS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CLPS leads in 4 of 6 categories, making it the strongest pick for growth and revenue expansion and capital preservation and lower volatility. Jinxin Technology Holding Company American Depositary Shares is the stronger pick specifically for profitability and margin quality and operational efficiency and capital deployment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
NAMI
Jinxin Technology Holding Company American Depositary Shares
The Growth Play

NAMI is the clearest fit if your priority is growth exposure and sleep-well-at-night.

  • Rev growth 7.0%, EPS growth -73.2%, 3Y rev CAGR 17.9%
  • Lower volatility, beta 0.73, Low D/E 3.4%, current ratio 2.17x
  • 5.0% margin vs CLPS's -1.3%
Best for: growth exposure and sleep-well-at-night
CLPS
CLPS Incorporation
The Income Pick

CLPS carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 3 yrs, beta 0.27, yield 14.6%
  • -78.5% 10Y total return vs NAMI's -91.3%
  • Beta 0.27, yield 14.6%, current ratio 1.58x
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthCLPS logoCLPS15.2% revenue growth vs NAMI's 7.0%
Quality / MarginsNAMI logoNAMI5.0% margin vs CLPS's -1.3%
Stability / SafetyCLPS logoCLPSBeta 0.27 vs NAMI's 0.73
DividendsCLPS logoCLPS14.6% yield; 3-year raise streak; the other pay no meaningful dividend
Momentum (1Y)CLPS logoCLPS-5.4% vs NAMI's -86.9%
Efficiency (ROA)NAMI logoNAMI9.7% ROA vs CLPS's -3.2%

NAMI vs CLPS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

NAMIJinxin Technology Holding Company American Depositary Shares
FY 2024
Service, Other
100.0%$16M
CLPSCLPS Incorporation
FY 2025
Other Member
100.0%$894,598

NAMI vs CLPS — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCLPSLAGGINGNAMI

Income & Cash Flow (Last 12 Months)

Evenly matched — NAMI and CLPS each lead in 3 of 6 comparable metrics.

NAMI and CLPS operate at a comparable scale, with $406M and $299M in trailing revenue. NAMI is the more profitable business, keeping 5.0% of every revenue dollar as net income compared to CLPS's -1.3%. On growth, CLPS holds the edge at +15.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricNAMI logoNAMIJinxin Technology…CLPS logoCLPSCLPS Incorporation
RevenueTrailing 12 months$406M$299M
EBITDAEarnings before interest/tax-$1M
Net IncomeAfter-tax profit-$4M
Free Cash FlowCash after capex$0
Gross MarginGross profit ÷ Revenue+28.8%+22.8%
Operating MarginEBIT ÷ Revenue+6.7%-1.4%
Net MarginNet income ÷ Revenue+5.0%-1.3%
FCF MarginFCF ÷ Revenue-8.8%-2.3%
Rev. Growth (YoY)Latest quarter vs prior year-0.7%+15.3%
EPS Growth (YoY)Latest quarter vs prior year-114.7%+75.8%
Evenly matched — NAMI and CLPS each lead in 3 of 6 comparable metrics.

Valuation Metrics

CLPS leads this category, winning 3 of 3 comparable metrics.
MetricNAMI logoNAMIJinxin Technology…CLPS logoCLPSCLPS Incorporation
Market CapShares × price$11M$25M
Enterprise ValueMkt cap + debt − cash-$2M$31M
Trailing P/EPrice ÷ TTM EPS3.60x-3.48x
Forward P/EPrice ÷ next-FY EPS est.
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple-0.21x
Price / SalesMarket cap ÷ Revenue0.19x0.15x
Price / BookPrice ÷ Book value/share0.46x0.43x
Price / FCFMarket cap ÷ FCF
CLPS leads this category, winning 3 of 3 comparable metrics.

Profitability & Efficiency

NAMI leads this category, winning 7 of 7 comparable metrics.

NAMI delivers a 94.8% return on equity — every $100 of shareholder capital generates $95 in annual profit, vs $-6 for CLPS. NAMI carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to CLPS's 0.59x. On the Piotroski fundamental quality scale (0–9), NAMI scores 4/9 vs CLPS's 2/9, reflecting mixed financial health.

MetricNAMI logoNAMIJinxin Technology…CLPS logoCLPSCLPS Incorporation
ROE (TTM)Return on equity+94.8%-6.1%
ROA (TTM)Return on assets+9.7%-3.2%
ROICReturn on invested capital-7.9%
ROCEReturn on capital employed+18.4%-9.8%
Piotroski ScoreFundamental quality 0–942
Debt / EquityFinancial leverage0.03x0.59x
Net DebtTotal debt minus cash-$87M$6M
Cash & Equiv.Liquid assets$93M$28M
Total DebtShort + long-term debt$6M$34M
Interest CoverageEBIT ÷ Interest expense
NAMI leads this category, winning 7 of 7 comparable metrics.

Total Returns (Dividends Reinvested)

CLPS leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in CLPS five years ago would be worth $3,073 today (with dividends reinvested), compared to $869 for NAMI. Over the past 12 months, CLPS leads with a -5.4% total return vs NAMI's -86.9%. The 3-year compound annual growth rate (CAGR) favors CLPS at 0.2% vs NAMI's -55.7% — a key indicator of consistent wealth creation.

MetricNAMI logoNAMIJinxin Technology…CLPS logoCLPSCLPS Incorporation
YTD ReturnYear-to-date-49.2%-10.3%
1-Year ReturnPast 12 months-86.9%-5.4%
3-Year ReturnCumulative with dividends-91.3%+0.5%
5-Year ReturnCumulative with dividends-91.3%-69.3%
10-Year ReturnCumulative with dividends-91.3%-78.5%
CAGR (3Y)Annualised 3-year return-55.7%+0.2%
CLPS leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

CLPS leads this category, winning 2 of 2 comparable metrics.

CLPS is the less volatile stock with a 0.27 beta — it tends to amplify market swings less than NAMI's 0.73 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CLPS currently trades 48.2% from its 52-week high vs NAMI's 9.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricNAMI logoNAMIJinxin Technology…CLPS logoCLPSCLPS Incorporation
Beta (5Y)Sensitivity to S&P 5000.73x0.27x
52-Week HighHighest price in past year$3.98$1.88
52-Week LowLowest price in past year$0.37$0.80
% of 52W HighCurrent price vs 52-week peak+9.7%+48.2%
RSI (14)Momentum oscillator 0–10036.149.8
Avg Volume (50D)Average daily shares traded67K15K
CLPS leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

CLPS is the only dividend payer here at 14.60% yield — a key consideration for income-focused portfolios.

MetricNAMI logoNAMIJinxin Technology…CLPS logoCLPSCLPS Incorporation
Analyst RatingConsensus buy/hold/sell
Price TargetConsensus 12-month target
# AnalystsCovering analysts
Dividend YieldAnnual dividend ÷ price+14.6%
Dividend StreakConsecutive years of raises3
Dividend / ShareAnnual DPS$0.13
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

CLPS leads in 3 of 6 categories (Valuation Metrics, Total Returns). NAMI leads in 1 (Profitability & Efficiency). 1 tied.

Best OverallCLPS Incorporation (CLPS)Leads 3 of 6 categories
Loading custom metrics...

NAMI vs CLPS: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is NAMI or CLPS a better buy right now?

For growth investors, CLPS Incorporation (CLPS) is the stronger pick with 15.

2% revenue growth year-over-year, versus 7. 0% for Jinxin Technology Holding Company American Depositary Shares (NAMI). Jinxin Technology Holding Company American Depositary Shares (NAMI) offers the better valuation at 3. 6x trailing P/E, making it the more compelling value choice. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — NAMI or CLPS?

Over the past 5 years, CLPS Incorporation (CLPS) delivered a total return of -69.

3%, compared to -91. 3% for Jinxin Technology Holding Company American Depositary Shares (NAMI). Over 10 years, the gap is even starker: CLPS returned -78. 5% versus NAMI's -91. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — NAMI or CLPS?

By beta (market sensitivity over 5 years), CLPS Incorporation (CLPS) is the lower-risk stock at 0.

27β versus Jinxin Technology Holding Company American Depositary Shares's 0. 73β — meaning NAMI is approximately 168% more volatile than CLPS relative to the S&P 500. On balance sheet safety, Jinxin Technology Holding Company American Depositary Shares (NAMI) carries a lower debt/equity ratio of 3% versus 59% for CLPS Incorporation — giving it more financial flexibility in a downturn.

04

Which is growing faster — NAMI or CLPS?

By revenue growth (latest reported year), CLPS Incorporation (CLPS) is pulling ahead at 15.

2% versus 7. 0% for Jinxin Technology Holding Company American Depositary Shares (NAMI). On earnings-per-share growth, the picture is similar: Jinxin Technology Holding Company American Depositary Shares grew EPS -73. 2% year-over-year, compared to -181. 4% for CLPS Incorporation. Over a 3-year CAGR, NAMI leads at 17. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — NAMI or CLPS?

Jinxin Technology Holding Company American Depositary Shares (NAMI) is the more profitable company, earning 5.

0% net margin versus -4. 3% for CLPS Incorporation — meaning it keeps 5. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NAMI leads at 6. 7% versus -4. 0% for CLPS. At the gross margin level — before operating expenses — NAMI leads at 28. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — NAMI or CLPS?

In this comparison, CLPS (14.

6% yield) pays a dividend. NAMI does not pay a meaningful dividend and should not be held primarily for income.

07

Is NAMI or CLPS better for a retirement portfolio?

For long-horizon retirement investors, CLPS Incorporation (CLPS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

27), 14. 6% yield). Both have compounded well over 10 years (CLPS: -78. 5%, NAMI: -91. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between NAMI and CLPS?

These companies operate in different sectors (NAMI (Communication Services) and CLPS (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: NAMI is a small-cap deep-value stock; CLPS is a small-cap high-growth stock. CLPS pays a dividend while NAMI does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

NAMI

Quality Business

  • Sector: Communication Services
  • Market Cap > $100B
  • Gross Margin > 17%
Run This Screen
Stocks Like

CLPS

High-Growth Disruptor

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Gross Margin > 13%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform NAMI and CLPS on the metrics below

Revenue Growth>
%
(NAMI: -0.7% · CLPS: 15.3%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.